ASCO 2019 Highlights: Advances in Multiple Myeloma

ASCO 2019 concluded on June 4th and we are excited about Multiple Myeloma updates from the largest gathering of oncologists, researchers and health professionals. The myeloma panel is talking to Dr. Joseph Mikhael, Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center and Chief Medical Officer, International Myeloma Foundation on advances in research, treatments and new myeloma programs that are on the anvil.
Myeloma Panel - Gary Petersen, Cynthia Chmielewski, Matt Goldman
Expert - Dr. Joseph Mikhael
Dr. Mikhael is a Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope Cancer Center. He is also the Chief Medical Officer of the International Myeloma Foundation (IMF). He also serves as a Councilor on the Executive of the American Society of Hematology. He specializes clinically in plasma cell disorders, namely multiple myeloma, amyloidosis and Waldenstrom’s macroglobulinemia.
RSVP HERE!